4-Bromo-2-(1-(phenylsulfonyl)-1H-indol-3-yl)-1H-imidazo[4,5-c]pyridine (28

4-Bromo-2-(1-(phenylsulfonyl)-1H-indol-4-yl)-1H-imidazo[4,5-c]pyridine (29).
4-Bromo-2-(1-(phenylsulfonyl)-1H-indol-5-yl)-1H-imidazo[4,5-c]pyridine (30
2-(1-(Phenylsulfonyl)-1H-indol-2-yl)-4-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridine
2-(1-(Phenylsulfonyl)-1H-indol-5-yl)-4-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridine
(36). 
2-(1-(Phenylsulfonyl)-1H-indol-6-yl)-4-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridine
(37). 
2-(1-(Phenylsulfonyl)-1H-indol-7-yl)-4-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridine
(38). 2. Figure S1 . Structures of known colchicine inhibitors
2-(1H-Indol-2-yl)-4-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridine (39).
2-(1H-Indol-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridine (40).
2-(1H-Indol-4-yl)-4-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridine (41).
2-(1H-Indol-6-yl)-4-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridine (43, 6-IIP).
2-(1H-Indol-7-yl)-4-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1H-imidazo[4,5-c]pyridine (44a
Molecular Modeling
Docking study was performed in Schrodinger Molecular Modeling Suite 2014 (Schrodinger Inc., Portland, OR) followeding a similar procedure as described before 17b using the DAMA colchicine-tubulin complex (Protein Data Bank code: 1SA0) as the template. All the compounds including native ligand were first prepared by LigPrep panel in Schrodinger software to generate at most 32 favored conformations for each compound under physiological pH and temperature.
Tubulin receptor grid was generated by taking off the native ligand but reserving the center binding site residue orientations. Then both the tubulin inhibitors investigated in this study and native ligand DAMA colchicine were docked into the same colchicine binding pocket and the output poses were minimized through molecular dynamics calculation. St. Louis, MO). The antiproliferation activities of all the compounds were tested with a MTS cell viability assay after 48 h incubation following the same procedure described before.
In Vitro Tubulin Polymerization Assay
HTS-tubulin polymerization assay kit (Cytoskeleton, Denver, CO) was used to determine the changes of tubulin polymerization profile in the presence of our compounds. Briefly, porcine brain tubulin (0.4 mg, >97% pure) was reconstituted in ice-cold 100 µL of general tubulin buffer containing 5 µM or 10 µM of the test compounds and incubated at 37 °C for tubulin polymerization (n = 3). Reaction system with same final concentration of DMSO (1%) was used as assay control. The absorbance of wavelength at 340 nm was kinetically read every 1 min for 60 min by a SYNERGY 4 microplate reader (Bio-Tek Instruments, Winooski, VT).
Cell Cycle Analysis
Human melanoma A375 cells or human prostate cancer PC-3 cells were cultured in 10 cm tissue culture dishes (n = 3) until the confluence reached 70%. Then the cells were starved to synchronize in FBS-free medium for 24 h before they were treated by tested compound solution at the concentrations of 10 nM or 50 nM for 24 h in 10% FBS growth medium. Cell pellets were harvested by trypsin and fixed in 70% ethanol overnight at -20 °C. Cellular DNA was stained with 50 µg/mL propidium iodide before they were analyzed in a BD LSR-II cytometer (BD Biosciences, San Jose, CA) with 10,000 cells sorted for each sample. Data were processed using Modfit 2.0 program (Verify Software House, Topsham, ME).
Liver Microsomal Stability Assay
The in vitro metabolic stability of the selected compounds were studied by incubating the test compounds (2 µM) in a total liver microsomal reaction system (1 mg/mL protein in 0.2 M of phosphate buffer solution (pH 7.4), 1.3 mM NADPH, 3.3 mM glucose-6-phosphate, and 0.4 U/mL glucose-6-phosphate dehydrogenase) at 37 °C in a shaking incubator (n =3). Pooled human liver microsomes (HLM) and pooled male CD1 mouse liver microsomes (MLM) were purchased from Xenotech, LLC (Lenexa, KS). Aliquots (100 µL) were sampled from the reaction mixtures at 0, 5, 10, 20, 30, 60, and 90 min after the beginning of the 37 °C incubation.
Each of the aliquots were quenched by adding 300 µL ice-cold acetonitrile. Samples were incubated on ice for 20 min then centrifuged at 10,000 g for 15 min at 4 °C, and the supernatant was analyzed by a LC-MS/MS system (AB Sciex API4500). For metabolite identification, the reaction mixture was incubated for 5 h with test compound at the concentration of 50 µM in the same conditions. The quenched samples were filtered through a 0.2 µm membrane then analyzed with a Water Xevo G2-S high resolution mass spectrometer. 
